Group One Trading
KITE

Group One Trading’s Kite Pharma, Inc. KITE Stock Holding History

Group One Trading’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-32,877
Closed -$4.58M – 5476
2017
Q2 		$3.41M Buy
32,877
+21,370
+186% +$1.74M 0.04% 643
2017
Q1 		$903K Sell
11,507
-3,101
-21% -$192K 0.01% 1403
2016
Q4 		$655K Buy
14,608
+9,761
+201% +$479K 0.01% 1604
2016
Q3 		$271K Buy
+4,847
New +$270K ﹤0.01% 2267
2016
Q1 		– Sell
-8,675
Closed -$420K – 5306
2015
Q4 		$535K Sell
8,675
-1,268
-13% -$89.3K 0.01% 1774
2015
Q3 		$554K Buy
+9,943
New +$625K 0.01% 1696
2015
Q1 		– Sell
-2,977
Closed -$200K – 5488
2014
Q4 		$172K Buy
+2,977
New +$125K ﹤0.01% 2419

Group One Trading's KITE Position: Q3 2017 in Review

Group One Trading sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 32,877 shares — an estimated $4.58M sold.

Group One Trading first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $3.41M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Group One Trading reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 32,877 Kite Pharma, Inc. shares in Q3 2017, an estimated $4.58M.
  • Group One Trading first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
  • Group One Trading's Kite Pharma, Inc. position peaked at $3.41M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.